Suppr超能文献

无视乳头水肿的特发性颅内高压的当前观点

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema.

作者信息

Mollan Susan P, Chong Yu Jeat, Grech Olivia, Sinclair Alex J, Wakerley Benjamin R

机构信息

Birmingham Neuro-Ophthalmology Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK.

Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston B15 2TT, UK.

出版信息

Life (Basel). 2021 May 24;11(6):472. doi: 10.3390/life11060472.

Abstract

The pseudotumor cerebri syndrome embraces disorders characterised by raised intracranial pressure, where the commonest symptom is headache (90%). Idiopathic intracranial hypertension without papilloedema (IIHWOP) is increasingly recognised as a source of refractory headache symptoms and resultant neurological disability. Although the majority of patients with IIHWOP are phenotypically similar to those with idiopathic intracranial hypertension (IIH), it remains uncertain as to whether IIHWOP is nosologically distinct from IIH. The incidence, prevalence, and the degree of association with the world-wide obesity epidemic is unknown. Establishing a diagnosis of IIHWOP can be challenging, as often lumbar puncture is not routinely part of the work-up for refractory headaches. There are published diagnostic criteria for IIHWOP; however, some report uncertainty regarding a pathologically acceptable cut off for a raised lumbar puncture opening pressure, which is a key criterion. The literature provides little information to help guide clinicians in managing patients with IIHWOP. Further research is therefore needed to better understand the mechanisms that drive the development of chronic daily headaches and a relationship to intracranial pressure; and indeed, whether such patients would benefit from therapies to lower intracranial pressure. The aim of this narrative review was to perform a detailed search of the scientific literature and provide a summary of historic and current opinion regarding IIHWOP.

摘要

假性脑瘤综合征包括以颅内压升高为特征的疾病,其中最常见的症状是头痛(90%)。无视乳头水肿的特发性颅内高压(IIHWOP)越来越被认为是难治性头痛症状及由此导致神经功能障碍的一个原因。尽管大多数IIHWOP患者在表型上与特发性颅内高压(IIH)患者相似,但IIHWOP在疾病分类学上是否与IIH不同仍不确定。其发病率、患病率以及与全球肥胖流行的关联程度尚不清楚。确立IIHWOP的诊断可能具有挑战性,因为腰椎穿刺通常并非难治性头痛检查的常规组成部分。已有关于IIHWOP的诊断标准发表;然而,一些报告指出对于腰椎穿刺初压升高这一关键标准在病理上可接受的临界值存在不确定性。文献几乎没有提供帮助指导临床医生管理IIHWOP患者的信息。因此,需要进一步研究以更好地理解导致慢性每日头痛发展的机制及其与颅内压的关系;实际上,还需研究此类患者是否会从降低颅内压的治疗中获益。本叙述性综述的目的是对科学文献进行详细检索,并总结关于IIHWOP的历史和当前观点。

相似文献

1
Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema.
Life (Basel). 2021 May 24;11(6):472. doi: 10.3390/life11060472.
5
Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache.
Front Neurol. 2018 Jun 26;9:503. doi: 10.3389/fneur.2018.00503. eCollection 2018.
6
Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine.
Neurology. 2006 Aug 8;67(3):419-23. doi: 10.1212/01.wnl.0000227892.67354.85.
7
The role of intracranial hypertension in the chronification of migraine.
Neurol Sci. 2015 May;36 Suppl 1:23-8. doi: 10.1007/s10072-015-2164-7.
8
Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain?
Neurol Sci. 2020 Dec;41(Suppl 2):417-421. doi: 10.1007/s10072-020-04641-w.
10
Cup-to-Disc Ratio in Idiopathic Intracranial Hypertension without Papilloedema.
Neuroophthalmology. 2014 Feb 25;38(2):69-73. doi: 10.3109/01658107.2013.874452. eCollection 2014.

引用本文的文献

2
Idiopathic Intracranial Hypertension in Neonates, Infants, and Toddlers.
J Clin Med. 2025 Jul 17;14(14):5084. doi: 10.3390/jcm14145084.
3
Diagnostic process, misdiagnosis and bias in suspected idiopathic intracranial hypertension: a retrospective observational cohort study.
BMJ Neurol Open. 2025 Mar 12;7(1):e000863. doi: 10.1136/bmjno-2024-000863. eCollection 2025.
4
Idiopathic intracranial hypertension in Asians: a retrospective dual-center study.
J Headache Pain. 2024 Sep 4;25(1):144. doi: 10.1186/s10194-024-01852-w.
6
Progress and recognition of idiopathic intracranial hypertension: A narrative review.
CNS Neurosci Ther. 2024 Aug;30(8):e14895. doi: 10.1111/cns.14895.
7
Transverse Sinus Stenting Reverses Medically Refractory Idiopathic Intracranial Hypertension.
Front Ophthalmol (Lausanne). 2022 Jun 21;2:885583. doi: 10.3389/fopht.2022.885583. eCollection 2022.
8
Managing idiopathic intracranial hypertension in the eye clinic.
Eye (Lond). 2024 Aug;38(12):2472-2481. doi: 10.1038/s41433-024-03140-y. Epub 2024 May 24.
9
Imaging the brain: diagnosis aided by structural features on neuroimaging studies.
Eye (Lond). 2024 Aug;38(12):2380-2391. doi: 10.1038/s41433-024-03142-w. Epub 2024 May 23.

本文引用的文献

1
The Potentially Modifiable Risk Factor in Idiopathic Intracranial Hypertension: Body Weight.
Neurol Clin Pract. 2021 Aug;11(4):e504-e507. doi: 10.1212/CPJ.0000000000001063.
3
Unilateral Papilledema in Idiopathic Intracranial Hypertension: A Case Series.
Can J Neurol Sci. 2022 Mar;49(2):278-281. doi: 10.1017/cjn.2021.79. Epub 2021 Apr 23.
4
Headache for ophthalmologists: current advances in headache understanding and management.
Eye (Lond). 2021 Jun;35(6):1574-1586. doi: 10.1038/s41433-021-01421-4. Epub 2021 Feb 12.
5
Telemetric monitoring in idiopathic intracranial hypertension demonstrates intracranial pressure in a case with sight-threatening disease.
Acta Neurochir (Wien). 2021 Mar;163(3):725-731. doi: 10.1007/s00701-020-04640-y. Epub 2021 Jan 7.
6
Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.
Headache. 2021 Jan;61(1):157-169. doi: 10.1111/head.14026. Epub 2020 Dec 14.
7
Optical coherence tomography confirms shunt malfunction and recurrence of raised intracranial pressure in optic atrophy.
Br J Neurosurg. 2022 Apr;36(2):185-191. doi: 10.1080/02688697.2020.1844146. Epub 2020 Nov 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验